REGN
Regeneron Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$78.41B
P/E Ratio
17.89
EPS
$41.46
Beta
0.40
52W High
$820.12
52W Low
$474.60
50-Day MA
$766.57
200-Day MA
$651.78
Dividend Yield
0.48%
Profit Margin
31.40%
Forward P/E
17.04
PEG Ratio
1.56
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Fundamentals
| Revenue (TTM) | $14.34B |
| Gross Profit (TTM) | $6.39B |
| EBITDA | $4.25B |
| Operating Margin | 23.10% |
| Return on Equity | 14.90% |
| Return on Assets | 5.91% |
| Revenue/Share (TTM) | $137.12 |
| Book Value | $304.65 |
| Price-to-Book | 2.48 |
| Price-to-Sales (TTM) | 5.47 |
| EV/Revenue | 4.991 |
| EV/EBITDA | 12.30 |
| Quarterly Earnings Growth (YoY) | -2.60% |
| Quarterly Revenue Growth (YoY) | 2.50% |
| Shares Outstanding | $103.90M |
| Float | $98.55M |
| % Insiders | 1.99% |
| % Institutions | 90.91% |
Historical Volatility
HV 10-Day
23.83%
HV 20-Day
29.36%
HV 30-Day
29.45%
HV 60-Day
27.78%
HV Rank
30.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($873.78 target)
2
Strong Buy17
Buy8
HoldData last updated: 3/25/2026